The 125-year-old pharma giant behind morphine and codeine reached a deal to extend the deadline for its $200 million payment to an opioid victims’ compensation trust.
Looking For Market Distribution? Download the Media Kit
The 125-year-old pharma giant behind morphine and codeine reached a deal to extend the deadline for its $200 million payment to an opioid victims’ compensation trust.